Area of research
Pulmonary and Respiratory Medicine · Infectious Diseases
Research interest
Research interests include Cystic Fibrosis Research Advances, COVID-19 Clinical Research Studies, Respiratory Support and Mechanisms, and Sepsis Diagnosis and Treatment.
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
Network burst activity in hippocampal neuronal cultures: the role of synaptic and intrinsic currents